| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/08/2001 | CA2378155A1 Colloidal composition for esthetic correction |
| 02/07/2001 | EP1074620A1 Monomeric protein of the TGF-beta family |
| 02/07/2001 | EP1074615A1 Methods for purification of Factor VII activating Protease, its proenzyme or a mixture of both forms, by affinity chromatography |
| 02/07/2001 | EP1074262A1 Laminaria algae extract, method of preparation and cosmetic or pharmaceutical compositions containing the same |
| 02/07/2001 | EP1074244A2 Topical composition comprising a tocopherol compound |
| 02/07/2001 | EP1074243A2 Cosmetic compositions |
| 02/07/2001 | EP1074240A2 Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
| 02/07/2001 | EP1073750A1 Preparation of human papillomavirus e1 having helicase activity and method therefor |
| 02/07/2001 | EP1073740A1 Polynucleotides isolated from skin cells and methods for their use |
| 02/07/2001 | EP1073658A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 02/07/2001 | EP1073639A1 Quinoline derivatives |
| 02/07/2001 | EP1073481A1 Solid borate-diol interaction products for use in wounds |
| 02/07/2001 | EP1073446A1 Skin whitening composition |
| 02/07/2001 | EP1073445A1 Substance mixture for topical application comprising olive oil and honey |
| 02/07/2001 | EP1073439A1 Pharmaceutical composition |
| 02/07/2001 | EP1073435A1 Substituted tricyclic pyrazole derivatives with protein kinase activity |
| 02/07/2001 | EP1073434A1 Ccr-3 receptor antagonists |
| 02/07/2001 | EP1073433A1 Skin rash prevention composition |
| 02/07/2001 | EP1073418A1 Aqueous composition comprising active ingredients for the de-pigmentation of the skin |
| 02/07/2001 | EP1073412A1 Skin care agents containing combinations of active agents consisting of vitamin a derivatives and ubi- or plastoquinones |
| 02/07/2001 | EP1073405A1 Plant extracts useful for fighting against hair loss and preparation |
| 02/07/2001 | EP1073333A1 S-rabeprazole compositions and methods |
| 02/07/2001 | EP1073332A1 R-rabeprazole compositions and methods |
| 02/07/2001 | CN1283183A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 02/07/2001 | CN1283181A Substituted beta-alanines |
| 02/07/2001 | CN1283115A Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 02/07/2001 | CN1282737A Intermediate product used for preparing substituted quinoline-2-formamide |
| 02/07/2001 | CN1282609A Plaster for eliminating pus and growing muscle |
| 02/07/2001 | CN1282608A Medicine 'Pifuning'- for treating skin disease |
| 02/07/2001 | CN1282606A Medicine (Shaotangqing) for treating burn and scald |
| 02/07/2001 | CN1282605A Prescription and preparing process of Chinese medicine for treating burn and scald |
| 02/07/2001 | CN1282596A Baiyinggao for treating internal and external injuries |
| 02/07/2001 | CN1282583A Exterior-applied ointment |
| 02/07/2001 | CN1282579A Exterior-applied medicine for treating ephelides |
| 02/07/2001 | CN1282574A Process for preparing health-care liquid to prevent cold injury and wet skin |
| 02/07/2001 | CN1282571A Use of crosslinked cation polymer in skin cosmetics and skin disease preparations |
| 02/07/2001 | CN1061546C Preparation for treating burns and empyrosis and its preparing process |
| 02/07/2001 | CN1061545C Chinese medicine ointment for burn and its scar |
| 02/06/2001 | US6184422 Cyclohexanediol derivatives |
| 02/06/2001 | US6184389 Feature a plurality of functional groups attached to backbone and phosphoramidate sites |
| 02/06/2001 | US6184252 2-amino-1,3-alkanediol compositions for inducing/stimulating hair growth and/or retarding hair loss |
| 02/06/2001 | US6184247 Method of increasing cell renewal rate |
| 02/06/2001 | US6184237 Substituted pyridine compounds and methods of use |
| 02/06/2001 | US6184235 2-phenyl benzimidazole derivatives as MCP-1 antagonists |
| 02/06/2001 | US6184226 Antiinflammatory agents for treatment of cardiovascular system disorders/respiratory system disorders, antiischemic agents |
| 02/06/2001 | US6184223 Reverse-turn mimetics and methods relating thereto |
| 02/06/2001 | US6184217 Administering antiinflammatory dosage of a ring-substituted indolocarbazole derivative compound; tumor necrosis factor (tnf) inhibitors |
| 02/06/2001 | US6184215 Treatment of skin conditions with oxysterol activators of LXRα |
| 02/06/2001 | US6184214 Hydrolysis of 2-dichlorophosphoryloxy-acrylonitrile to form 2-hydroxyacrylamide-o-monophosphate; antiischemic agents for treating disorders due to the lack of atp |
| 02/06/2001 | US6184212 Antisense modulation of human mdm2 expression |
| 02/06/2001 | US6183775 Buccal delivery system |
| 02/06/2001 | US6183766 Lipophilic skin moisturizing agent; degreasing agent selected from the group consisting of: silicones, wax materials, powders, fluorochemicals and mixtures thereof; optionally a thickener, a humectant, a perfume; and water. |
| 02/06/2001 | US6183593 Curable blend |
| 02/06/2001 | CA2315309A1 Process for the preparation in pure form of the protease activating blood clotting factor vii, its proenzyme or a mixture of both proteins by means of affinity chromatography |
| 02/06/2001 | CA2314849A1 Topical composition comprising a tocopherol compound |
| 02/06/2001 | CA2220696C Improved method for controlling ectoparasites |
| 02/06/2001 | CA2147807C Bicyclic-aromatic compounds; pharmaceutical and cosmetic compositions containing them and uses |
| 02/06/2001 | CA2141572C Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
| 02/06/2001 | CA2106299C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 02/06/2001 | CA2024789C Compounds for the treatment of inflammation and allergy |
| 02/06/2001 | CA2003538C Collagen-polymer conjugates |
| 02/01/2001 | WO2001007628A2 Human synthetases |
| 02/01/2001 | WO2001007612A2 Receptors and associated proteins |
| 02/01/2001 | WO2001007604A1 Isolated peptide of the horny layer and use thereof |
| 02/01/2001 | WO2001007595A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | WO2001007471A2 Cell cycle and proliferation proteins |
| 02/01/2001 | WO2001007470A2 Human nervous system-associated proteins |
| 02/01/2001 | WO2001007461A1 Antisense modulation of mekk5 expression |
| 02/01/2001 | WO2001007459A1 29 human secreted proteins |
| 02/01/2001 | WO2001007440A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 02/01/2001 | WO2001007424A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 02/01/2001 | WO2001007417A1 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 02/01/2001 | WO2001007405A2 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 02/01/2001 | WO2001007073A1 Novel use of hypo-osmotic saline solutions and medicine based on said solutions |
| 02/01/2001 | WO2001007057A1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 02/01/2001 | WO2001007035A1 Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 02/01/2001 | WO2001007006A1 Association of fibrillin and a cyanophyta extract, preparation method and use as medicine |
| 02/01/2001 | WO2001007005A1 Use of a protein fraction of the seed of the vigna trilobata-plant in a cosmetic or dermopharmaceutical composition |
| 02/01/2001 | WO2001006991A1 Oil-in-water emulsion with improved stability |
| 02/01/2001 | WO2001006988A2 Super-active porcine growth hormone releasing hormone analog |
| 02/01/2001 | WO2001006984A2 Small molecules useful in the treatment of inflammatory disease |
| 02/01/2001 | WO2001006829A2 Linkage of agents to tissue |
| 02/01/2001 | WO2000061175A3 Use of pegylated interferon alpha in melanoma therapy |
| 02/01/2001 | WO2000053742A3 Polynucleotides and proteins encoded thereby |
| 02/01/2001 | WO2000053733A3 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 02/01/2001 | WO2000047194A3 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| 02/01/2001 | WO2000038717A3 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 02/01/2001 | WO2000037107A3 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 02/01/2001 | DE19935771A1 Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with cyclic substructures in the side chains, to processes and intermediates for their preparation and to the use for the preparation of medicaments |
| 02/01/2001 | DE19934458A1 Composition for treating pigmentation disorders, e.g. vitiligo, containing the protein DCoH, or related nucleic acids, antibodies or antisera |
| 02/01/2001 | CA2383690A1 29 human secreted proteins |
| 02/01/2001 | CA2383017A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 02/01/2001 | CA2380317A1 Human synthetases |
| 02/01/2001 | CA2380226A1 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | CA2379824A1 Novel use of hypo-osmotic saline solutions and medicine based on said solutions |
| 02/01/2001 | CA2379801A1 Receptors and associated proteins |
| 02/01/2001 | CA2379784A1 Cell cycle and proliferation proteins |
| 02/01/2001 | CA2379777A1 Isolated peptide of the horny layer and use thereof |
| 02/01/2001 | CA2378395A1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 02/01/2001 | CA2378372A1 Oil-in-water emulsion with improved stability |